FindTrial
Sign In

markers that aid in the detection of kidney disease in diabetes

Transcriptomics in diabetic kidney disease- pilot study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087400
Enrollment
5
Registered
2025-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Nil: Nil Intervention2: nil: nil

Sponsors

Manipal Academy of higher education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with DKD of GFR category G2 and G3a/G3b Adult patients within the age of 30 to 65 years Patients who are on regular follow-up at Kasturba Hospital for more than 1 year atleast.

Exclusion criteria

Exclusion criteria: History of acute kidney injury over the past 1 year History of addition/ dose change of medications History of new event History of nephrolithiasis/ urinary tract stones History of malignancy Patients with less thsn 12 months follow up Other causes of kidney disease that develops during the course of follow up

Design outcomes

Primary

MeasureTime frame
We expect to identify miRNAs involved in disease pathogenesis and progression of DKD. Upregulation/downregulation of specific miRNA could help us understand the variable prognosis of DKD. MiRNA profiling and analysis could enable us to identify diagnostic and therapeutic markers in management of DKD.Timepoint: 4-8weeks—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactCynthia Amrutha Sukumar

Manipal Academy of higher education

cynthiaamrutha@gmail.com07259415415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026